Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6Y0B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,986
Award facts
- Contract value 100% obligated
- $35,985.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,985.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. The order, which carries an ultimate completion date of January 27, 2026, was competitively awarded with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal military healthcare systems and leverages its extensive federal contracting experience to fulfill this supply requirement.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities and other federal healthcare programs worldwide. ENBREL, a biologic medication used primarily for rheumatoid arthritis and other autoimmune conditions, represents the type of specialty pharmaceutical product commonly procured through DLA's medical supply chain to support the Defense Health Agency and military personnel healthcare needs.
Quick answers
Who was awarded contract SPE2DR26F6Y0B?
SPE2DR26F6Y0B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F6Y0B worth?
The government has obligated $35,986 on SPE2DR26F6Y0B.
Is contract SPE2DR26F6Y0B an order under another contract?
Yes. SPE2DR26F6Y0B is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6Y0B competed?
The extent of competition for SPE2DR26F6Y0B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award